Active Ingredient/Content
- Ibandronate Sodium Monohydrate 168.75mg (Ibandronic acid 150mg)
|
Efficacy/Indication
- Treatment and prevention of osteoporosis in postmenopausal women and glucocorticoidinduced osteoporosis in men and women who are either initiating or continuing systemic glucocorticosteroids.
- Treatment to increase bone mass in men with osteoporosis. Treatment of Paget\'s disease of bone in men and women.
|
Administration/Dosage
- Adults: 1 tab(150mg) once a month
|